Image credit: Nushin Rashidian

CBD’s Potential for Reproductive Harms Among “Big Reasons” Behind FDA’s Punt on Rules

The FDA is seeking a “harm reduction framework” as it works with Congress on a path for CBD, according to the agency’s Cannabis Product Committee lead.


Cannabis Regulators Work to Forge a Path on Interstate Commerce 

States along the west coast have already passed laws to allow for “controlled” interstate commerce – when federal law changes.

New York

New York’s Cannabis Advisory Board Urges Regulators to Seek Its Input

The board held its first meeting on 2024 on Tuesday to discuss myriad priorities and concerns, including out-of-state-brands, relief for growers, and how to spend cannabis tax revenue.


Germany’s Parliament Passes Bill to Legalize Cannabis for Adults

If the bill clears its remaining steps without delay, including consideration by one more legislative body, it is on track to take effect in April.